Results 191 to 200 of about 1,745,820 (365)

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Two Cases of Massively Prolapsed Patent Vitellointestinal Duct

, 2017
Sudhir Singh, Digamber Chaubey, Jiledar Rawat, Gurmeet Singh   +3 more
openalex   +2 more sources

Scientific Research and Patents [PDF]

, 1944

openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Patent protection of biological genetic resources based on deep learning and artificial intelligence. [PDF]

Sci Rep
Liu Z, Liu L.
europepmc   +1 more source

The dynamics of patent citations [PDF]

The use of patent citations as a measure of patent "quality" increased dramatically in recent years. I estimate the hazard of patent citation, and find evidence of unobserved heterogeneity.
Marco, Alan C.
core  

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

A comprehensive review of patents in dentistry: An in-depth examination and evaluation. [PDF]

J Conserv Dent Endod
Kalgeri SH, Deepa BV, Shivakumar AT, Doddawad VG, Kumar BS, Shalini HS.   +5 more
europepmc   +1 more source

Text matching to measure patent similarity

, 2018
Sam Arts, B. Cassiman, Juan Carlos Gomez
semanticscholar   +1 more source

Endogenous R&D and Intellectual Property Laws in Developed and Emerging Economies [PDF]

The incentive of providing protection of intellectual property has been analyzed, both for an emerging economy as well as for a developed economy. The optimal patent length and the optimal patent breadth within a country are found to be positively ...
Bagchi, Aniruddha, Roy, Abhra
core   +1 more source